×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Michael J. Labarre

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 25, 2025Sale$58.0510,000580,534186,153Feb 27, 2025, 06:32 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 26, 2025Sale$58.1210,000581,244176,053Feb 27, 2025, 06:32 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 27, 2025Sale$58.281,69798,902173,856Feb 27, 2025, 06:32 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 23, 2025Tax Payment (Shares)$57.752,410139,178195,453Feb 24, 2025, 05:11 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 23, 2025Option/RSU Exercise-4,747-197,863Feb 24, 2025, 05:11 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 15, 2025Option/RSU Exercise-3,386-177,142Feb 18, 2025, 06:42 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 16, 2025Tax Payment (Shares)$58.2913,988815,361193,116Feb 18, 2025, 06:42 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 16, 2025Option/RSU Exercise-31,266-196,729Feb 18, 2025, 06:42 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 15, 2025Tax Payment (Shares)$58.291,30476,010175,838Feb 18, 2025, 06:42 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICEROct 15, 2024Option/RSU Exercise$18.1510,000181,455183,756Oct 16, 2024, 06:53 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICEROct 15, 2024Sale$53.7510,000537,469173,833Oct 16, 2024, 06:53 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICEROct 16, 2024Option/RSU Exercise$19.9810,000199,800183,756Oct 16, 2024, 06:53 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICEROct 16, 2024Sale$53.2610,000532,590173,756Oct 16, 2024, 06:53 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERSep 17, 2024Option/RSU Exercise$16.6510,000166,500183,756Sep 18, 2024, 06:49 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERSep 17, 2024Sale$62.8810,000628,780173,756Sep 18, 2024, 06:49 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERSep 18, 2024Option/RSU Exercise$16.6510,000166,500183,756Sep 18, 2024, 06:49 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERSep 18, 2024Sale$62.0310,000620,316175,793Sep 18, 2024, 06:49 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERAug 27, 2024Option/RSU Exercise$18.415,580102,728173,756Aug 27, 2024, 07:49 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERAug 21, 2024Sale$61.7510,000617,470168,276Aug 21, 2024, 06:03 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERAug 20, 2024Option/RSU Exercise$16.6510,000166,500178,176Aug 21, 2024, 06:03 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERAug 20, 2024Sale$61.0610,000610,550168,176Aug 21, 2024, 06:03 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERAug 21, 2024Option/RSU Exercise$16.6510,000166,500178,176Aug 21, 2024, 06:03 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJul 24, 2024Option/RSU Exercise$15.1910,000151,854178,176Jul 24, 2024, 05:48 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJul 24, 2024Sale$55.1210,000551,150168,176Jul 24, 2024, 05:48 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJul 23, 2024Option/RSU Exercise$8.1110,00081,100178,176Jul 24, 2024, 05:48 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJul 23, 2024Sale$54.8910,000548,873173,467Jul 24, 2024, 05:48 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJun 18, 2024Option/RSU Exercise$8.1110,00081,100178,176Jun 20, 2024, 04:17 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJun 18, 2024Sale$49.4310,000494,260168,176Jun 20, 2024, 04:17 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERMay 22, 2024Sale$45.3810,000453,840168,176May 22, 2024, 05:24 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERMay 21, 2024Option/RSU Exercise$8.1110,00081,100178,176May 22, 2024, 05:24 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERMay 21, 2024Sale$45.1610,000451,640168,176May 22, 2024, 05:24 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERMay 22, 2024Option/RSU Exercise$8.1110,00081,100178,176May 22, 2024, 05:24 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERApr 17, 2024Option/RSU Exercise$8.1110,00081,100178,176Apr 17, 2024, 07:22 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERApr 17, 2024Sale$38.4910,000384,890168,176Apr 17, 2024, 07:22 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERApr 16, 2024Option/RSU Exercise$8.1110,00081,100178,176Apr 17, 2024, 07:22 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERApr 16, 2024Sale$38.3510,000383,500168,176Apr 17, 2024, 07:22 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERMar 26, 2024Option/RSU Exercise$11.2011,618130,160168,176Mar 26, 2024, 07:38 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERMar 13, 2024Option/RSU Exercise$10.6610,000106,638166,558Mar 13, 2024, 05:22 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERMar 13, 2024Sale$42.2710,000422,730156,558Mar 13, 2024, 05:22 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERMar 12, 2024Option/RSU Exercise$12.0710,000120,700166,558Mar 13, 2024, 05:22 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERMar 12, 2024Sale$41.6410,000416,370156,558Mar 13, 2024, 05:22 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 27, 2024Sale$39.9510,000399,460159,087Feb 28, 2024, 06:49 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 28, 2024Option/RSU Exercise$8.117,47160,590164,029Feb 28, 2024, 06:49 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 28, 2024Sale$39.5510,000395,463156,558Feb 28, 2024, 06:49 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 16, 2024Option/RSU Exercise-10,376-171,247Feb 20, 2024, 06:59 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 16, 2024Tax Payment (Shares)$36.105,257189,778169,087Feb 20, 2024, 06:59 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 15, 2024Tax Payment (Shares)$35.915,040180,986163,968Feb 16, 2024, 05:47 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 15, 2024Option/RSU Exercise-3,386-160,529Feb 16, 2024, 05:47 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 10, 2024Tax Payment (Shares)$35.492,901102,956157,143Feb 13, 2024, 04:18 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 10, 2024Option/RSU Exercise-8,133-160,044Feb 13, 2024, 04:18 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJan 16, 2024Option/RSU Exercise$12.0710,000120,700161,911Jan 18, 2024, 04:07 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJan 16, 2024Sale$36.0010,000360,000151,911Jan 18, 2024, 04:07 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJan 17, 2024Option/RSU Exercise$12.0710,000120,700161,911Jan 18, 2024, 04:07 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJan 17, 2024Sale$36.0010,000360,000151,911Jan 18, 2024, 04:07 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERDec 13, 2023Sale$40.3910,000403,940151,911Dec 13, 2023, 07:48 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERDec 12, 2023Option/RSU Exercise$13.5510,000135,547161,911Dec 13, 2023, 07:48 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERDec 12, 2023Sale$39.6310,000396,322152,554Dec 13, 2023, 07:48 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERDec 13, 2023Option/RSU Exercise$12.0710,000120,700161,911Dec 13, 2023, 07:48 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERNov 14, 2023Sale$39.0810,000390,790151,911Nov 16, 2023, 04:18 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERNov 15, 2023Option/RSU Exercise$13.8110,000138,100161,911Nov 16, 2023, 04:18 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERNov 15, 2023Sale$39.7910,000397,880151,911Nov 16, 2023, 04:18 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERNov 14, 2023Option/RSU Exercise$14.3210,000143,173160,203Nov 16, 2023, 04:18 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICEROct 17, 2023Option/RSU Exercise$19.9810,000199,800161,911Oct 17, 2023, 07:28 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICEROct 17, 2023Sale$36.5210,000365,200151,911Oct 17, 2023, 07:28 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERSep 19, 2023Option/RSU Exercise$19.9810,000199,800161,911Sep 19, 2023, 04:09 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERSep 19, 2023Sale$39.1010,000390,980151,911Sep 19, 2023, 04:09 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERAug 22, 2023Option/RSU Exercise$19.6810,000196,778159,986Aug 23, 2023, 05:08 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERAug 22, 2023Sale$42.4110,000424,070151,911Aug 23, 2023, 05:08 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJul 18, 2023Option/RSU Exercise$15.3020,000306,098151,911Jul 19, 2023, 04:10 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJul 18, 2023Sale$40.4310,000404,300141,911Jul 19, 2023, 04:10 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJun 21, 2023Sale$36.0010,000360,000141,911Jun 22, 2023, 06:20 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJun 21, 2023Option/RSU Exercise$18.4110,000184,100151,911Jun 22, 2023, 06:20 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERApr 18, 2023Option/RSU Exercise$18.4110,000184,100151,911Apr 19, 2023, 06:07 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERApr 18, 2023Sale$36.0010,000360,000141,911Apr 19, 2023, 06:07 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 27, 2023Option/RSU Exercise$18.412,98454,935144,895Apr 19, 2023, 06:01 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 27, 2023Sale$49.552,984147,854141,911Apr 19, 2023, 06:01 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 27, 2023Sale$49.5510,000495,483141,911Feb 28, 2023, 04:59 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 16, 2023Option/RSU Exercise-6,112-151,805Feb 21, 2023, 07:05 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 16, 2023Sale$49.262,878141,770148,927Feb 21, 2023, 07:05 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 15, 2023Tax Payment (Shares)$49.201,17057,564145,693Feb 17, 2023, 06:29 AM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 15, 2023Option/RSU Exercise-3,386-146,863Feb 17, 2023, 06:29 AM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 15, 2023Sale$48.3910,000483,940143,477Feb 17, 2023, 06:29 AM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 10, 2023Tax Payment (Shares)$48.922,951144,363148,319Feb 14, 2023, 05:24 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 10, 2023Option/RSU Exercise-8,133-151,270Feb 14, 2023, 05:24 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 12, 2023Tax Payment (Shares)$48.922,725133,307153,477Feb 14, 2023, 05:24 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERFeb 12, 2023Option/RSU Exercise-7,883-156,202Feb 14, 2023, 05:24 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERJan 17, 2023Sale$50.4610,000504,590144,259Jan 18, 2023, 07:07 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERDec 13, 2022Sale$58.6710,000586,675158,202Dec 13, 2022, 06:09 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, CHIEF TECHNICAL OFFICERNov 15, 2022Sale$54.1310,000541,263166,260Nov 16, 2022, 07:25 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 15, 2022Tax Payment (Shares)$34.431,17040,283173,137Feb 17, 2022, 06:04 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 15, 2022Option/RSU Exercise-3,386-174,307Feb 17, 2022, 06:04 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 14, 2022Option/RSU Exercise-5,771-172,916Feb 14, 2022, 07:29 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 10, 2022Tax Payment (Shares)$34.942,992104,540161,987Feb 14, 2022, 07:29 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 10, 2022Option/RSU Exercise-8,133-164,979Feb 14, 2022, 07:29 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 12, 2022Tax Payment (Shares)$34.202,72593,195167,145Feb 14, 2022, 07:29 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 12, 2022Option/RSU Exercise-7,883-169,870Feb 14, 2022, 07:29 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerFeb 14, 2022Tax Payment (Shares)$33.641,99567,112170,921Feb 14, 2022, 07:29 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerOct 12, 2021Option/RSU Exercise$13.108,050105,455156,846Oct 12, 2021, 07:06 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerOct 01, 2021Option/RSU Exercise$13.1029,450385,795178,246Oct 01, 2021, 07:32 PM
HALOHALOZYME THERAPEUTICS, INC.Michael J. LabarreSVP, Chief Technical OfficerOct 01, 2021Sale$39.9329,4501,175,968148,796Oct 01, 2021, 07:32 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe